US WorldMeds, LLC

Privately held: no public share price

Assets

(2 total)
2Total Assets
1Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
Showing 2 of 2 assets
Target & Modality
Approved
MAGE-A4Cell therapy
Soft Tissue Sarcoma
Synovial Sarcoma
Phase 2
NY-ESO-1 / LAGE-1a (HLA-A*02)Cell therapy
Soft Tissue Sarcoma
Myxoid/Round Cell Liposarcoma

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.